ZimVie Announces Over 2,000 Children Have Received The Tether VBT

WESTMINSTER, Colo., Oct. 24, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced that over 2,000 children worldwide have been treated with The Tether Vertebral Body Tethering System. The Tether was approved as a Humanitarian Device by the FDA in 2019, based on over seven years of clinical data. Over fifty surgeons have performed VBT using the market-leading Tether system to treat patients diagnosed with adolescent idiopathic scoliosis.

Dr. Baron Lonner, Chief of Minimally Invasive Scoliosis Surgery and Pediatric Spine at Mount Sinai Hospital and Professor of Orthopaedic Surgery at Icahn School of Medicine in New York, shared, “I have been in practice dedicating my career to the treatment of patients with scoliosis for 28 years. The Tether has been an amazing advance that has allowed my patients to have correction of their scoliosis while avoiding a fusion, with a faster return to sports and other activities. It has been a game changer.”

“Having brought this technology to over 2,000 children is a milestone that serves as a reminder of our commitment to put patients first, especially those for whom our products can have such profound and prolonged impact,” added Rebecca Whitney, Global President of ZimVie Spine. “The Tether is an important and inspirational part of our motion preservation portfolio. We remain dedicated to developing the market for vertebral body tethering and restoring daily life for this special group of patients.”

About The Tether
The Tether is a Humanitarian Device authorized by Federal law for use in the treatment of skeletally immature patients that require surgical treatment to obtain and maintain correction of progressive idiopathic scoliosis, with a major Cobb angle of 30 to 65 degrees whose osseous structure is dimensionally adequate to accommodate screw fixation, as determined by radiographic imaging. Patients should have failed bracing and/or be intolerant to brace wear. The effectiveness of this device for this use has not been demonstrated. Post-operative risks include inadequate curve correction, overcorrection of the instrumented curve, cord breakage, and bone screw migration. Full contraindication and risk information can be found at myscoliosis.com.